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Abstract
Obese women are at increased risk of death from cervical cancer
compared to non-obese women. Yet, research indicates a lower rate
of cervical cancer screening among obese women, especially severely
obese white women. Cited reasons for delaying screening include
embarrassment, perceived weight stigma, lack of appropriately sized
examination equipment and poor patient-provider communication.
Parental acceptance of the Human Papillomavirus (HPV) vaccine
for overweight adolescent females may decrease the incidence of
cervical cancer among obese women in later years. This study seeks
to determine the Human Papillomavirus (HPV) vaccination status of
females, ages 11 to 21 years, in a university-based pediatric practice
and to determine the correlation between HPV vaccine status and
body mass index (BMI).
Methods: We reviewed 800 randomly selected paper medical
charts of females, ages 11 to 21 years, enrolled in a university-based
pediatric practice as of October 31, 2008. Data collected included age,
height, weight, BMI, race, insurance carrier, immunizations, sexually
transmitted infections (STIs) and documentation of STI prevention
counseling. Statistical analysis was performed to determine
associations among risk factors and outcome variables.

Results: 800 charts reviewed; 91 were incomplete due to missing
documentation of immunizations. The remaining 709 charts included
338 (48.2%) African Americans; 302 (43.1%) Whites; 26 (3.7%)
Hispanics; and 35 (5%) other. Approximately 28.2% had current HPV
vaccine status. There was no correlation between HPV vaccination
status and BMI (p >0.05).

Conclusions: Our study fails to demonstrate higher HPV current
vaccination status with increasing BMI. Healthcare providers should
continue to encourage HPV vaccination.
Keywords: BMI; Cervical cancer; Health promotion; Human
papillomavirus vaccination; Obesity; Risk-taking behavior

Several factors influence parental acceptance of vaccines
including, understanding of the health consequences of diseases;
knowledge of vaccine benefits and risks; influence of media
and celebrities; and other social, behavioral and environmental
variables [2]. Although parental concern that HPV vaccine
may lead to promiscuity has not been substantiated [3], HPV
vaccination rates among adolescents remain low. In 2010, the
Centers for Disease Control estimated that 48.7 % of 13- to 17year-olds had received one dose the HPV vaccine and 32% had
received all 3 doses versus 44.3% and 26.7% respectively in
2009 [4].
Infection with HPV 16 and 18 is the most significant risk/
causative factor in cervical cancer etiology [5]. The incidence of
cervical cancer among obese women is higher compared to nonobese women [6]. Since childhood overweight tracks into young
adulthood [7], increasing HPV vaccination among adolescents
is warranted in view of the finding that disparities in cervical
cancer screening by body weight persist for white women with
severe obesity [8]. Reduced cervical cancer among obese women
could be achieved if we improved compliance rates for HPV
vaccination among adolescent females, especially overweight/
obese adolescents.

This study seeks to determine the HPV vaccination status of
females, ages 11 to 21 years, in the University of Toledo pediatric
practice and to determine the correlation between HPV vaccine
status and body mass index (BMI). Since overweight/obese
females are at increased risk of cervical cancer, our research
question is whether HPV vaccination status increases with
increasing BMI.

Methods

HPV Vaccine Status and BMI Correlation

Participants

Age-appropriate vaccinations have proven to be successful
public health measures to prevent and control infectious diseases.
High school students with extreme obesity participate in risk-taking
behavior (such as unprotected sexual activity, substance abuse,
and drinking) similar to healthy weight peers [1]. Overweight/
obese adolescents represent an at-risk group for cervical cancer in
later years and possible underutilization of HPV vaccination.

The study took place at the University of Toledo, Toledo,
Ohio. The pediatric outpatient practice enrolled patients from
birth until age 21 year and the study population is representative
of the Lucas County population based on the 2009 census. The
University of Toledo outpatient pediatric practice recommends
the HPV vaccine at age 11 years. Medicaid covers the HPV vaccine
for ages 9 thru 18 years and the commercial insurers cover the
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vaccine for ages 9 thru 26 years or ages 8 thru 27 years. After
approval by the University of Toledo Institutional Review Board
(IRB) the study was started as the scholarly project by one of
the authors who was a third year pediatric resident (EM) and
her faculty mentor (JRG). The other author (HD) was contracted
as the statistician and has collaborated with JRG on previous
research studies.

A representative from the pediatric billing staff generated a
computerized list of female patients, ages 11 to 21 years, who
were enrolled in the practice as of October 31, 2008. We randomly
selected 800 of these patients. Their paper charts were reviewed
between January 2009 and October 31, 2009 by one author (EM)
using an IRB-approved data collection form. To protect patient
confidentiality, all charts were assigned a random number
code. The key for the codes was maintained by the PI (EM). The
IRB-approved data collection form used to review the charts
included age; height; weight and BMI (kg/m2) as recorded on
the most recent physical exam; race/ethnicity; documentation of
vaccines recorded on the certificate of immunization compliance
form; parental refusal of vaccines; documentation of sexual
activity status; documentation of positive test(s) for Neisseria
gonorrhoeae (GC), Chlamydia trachomatis, Herpes simplex,
Rapid Plasma Reagin (RPR), and/or Human immunodeficiency
virus (HIV); documentation of sexually transmitted infection
prevention counseling; any recommendations for additional
sexually transmitted infection screening; and type of medical
insurance. Vaccination status was deemed “current” if the ageappropriate number of shots, based on 2009 Centers for Disease
Control Advisory Committee on Immunizations Practices (ACIP)
recommendations, was documented. The data was analyzed using
Fisher’s exact test, Pearson Chi-square test, logistic regression,
and general linear model.

Statistics

Statistical analysis was performed using SAS 9.2 and SPSS 18.
Pearson chi-square test, Fisher’s exact test, logistic regression and
general linear model were applied to evaluate the associations
among risk factors and outcome variables. Kappa coefficients
were determined to evaluate degrees of agreement between
vaccines. Cochran-Armitage trend test was applied to relate
the number of HPV vaccinations with history of STI. Statistical
significance was claimed at 95% confidence interval (p<0.05).

Results

Of the 800 charts reviewed, 91 charts did not have
documentation of immunization and were removed from further
analysis. The remaining 709 charts included 338 (48.2%) African
Americans; 302 (43.1%) Whites; 26 (3.7%) Hispanics, and 35
(5%) others. Subjects were between 11 and 21 years old with
mean age 14.9 ± 2.4 years old. The study population consisted of
16.1% (106/658) overweight subjects (BMI between 85th and 95th
percentile) and 22.1% (146/658) obese subjects (BMI greater
than the 95th percentile). BMI percentile was not associated
with HPV immunization status or type of insurance. Overweight
and obese subjects were more likely to have a history of STI as
compared to normal weight subjects. History of STI was reported
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in 19.4% of overweight subjects and 19.8% of obese subjects
versus 12.1% of normal weight subjects (p = 0.04). There was an
increasing trend of sexual activity relative to BMI status. Sexual
activity was reported in 47.9% of normal weight subjects, 51.3%
of overweight subjects and 57.0% of obese subjects (p = 0.09).
There was no association between HPV vaccination status and
sexual activity (> 0.05).

Whites subjects were more likely to have current HPV status
as compared to other subjects (Whites 32%; African American
29%; Hispanics 8%; other 10% {p = 0.0085}). African American
subjects had a higher rate of sexual activity (Whites 40%; African
American 61%; Hispanic 40%; other 32% { p = 0.0001}) and
history of STI (Whites 6%, African American 24%, Hispanics 8%,
other 4% {p = 0.0001}). The definition of immunization status
along with the distribution of vaccine shots are listed in Table
1. Only 1.5% (10/687) of parents refused vaccination for their
child. The reason for refusal was not documented. Approximately
28.2% (192/680) of subjects completed all three doses of HPV
vaccines. The highest proportion of current status was noted for
MMR (619/654 = 94.7%). HPV vaccine had slight agreement with
Menactra (Kappa = 0.143; p<0.0001) and Tdap (Kappa = 0.08; p
= 0.0299) (Table 2). Subjects with current HPV status were more
likely to have current Menactra (96% vs. 75%) and Tdap (52%
versus 43%) as compared to subjects without current HPV status.
Approximately 45.2% of subjects had concordant immunization
status between HPV and Menactra. Only 55.9% of subjects had
concordant HPV and Tdap current status. The discordance was
due to a higher Tdap vaccination rate than HPV rate. HepB had
general agreement with DTap, IPV, HIB, and Menactra.
A history of STI was correlated with current status of HPV
(Table 3). Subjects with documentation of STI were trended
to have more shots of HPV (Cochran-Armitage trend test,
p-value=0.0041) and were more likely to have current status of
HPV (43.5% vs. 26.1%, p=0.005). Thirty-five percent (233/636)
of subjects with documentation of insurance had commercial
insurance and 65% (432/636) had Medicaid insurance. There
was no correlation between insurance and HPV vaccination
status.

Discussion

In this single center, retrospective chart review, there was
no association between HPV vaccination status and BMI. Based
on a limited literature review (Pubmed and Pubmed health), we
were unable to identify any previous publication studying the
relationship between HPV vaccine status and BMI. (Keywords
used were ‘HPV vaccination and obesity’; ‘HPV vaccination and
body mass index’; ‘Vaccination and obesity’; ‘vaccination and
body mass index’; ‘Human papilloma virus and obesity’). This lack
of data suggests that additional research in this area is warranted
to determine if our findings are corroborated by future studies.
We also found no association between HPV vaccination status
and type of insurance. Zimet et al [9] found that parents with less
education, those with Medicaid insurance, and those attending
an urban clinic were more likely to be high vaccine acceptors.
In contrast, other studies have indicated that these same factors
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Table 1: Status and Distribution of Vaccination.
Current
Current
Vaccine
Definition
Status
627
Hep B
3 or more shots
(96.5%)
619
MMR
2 shots
(94.7%)
598
IPV
4 or more shots
(91.9%)
543
Meningococcal
1 shot
(80.9%)
192
HPV
3 shots
(28.2%)
2 shots or had the
201
Varicella
disease
(31.9%)
353
HIB
4 or more shots
(54.2%)
301
DTAP/Tdap
6 or more shots
(44.1%)
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0 Shot

1 Shot

2 Shots

3 Shots

4 Shots

9 (1.4%)

6 (0.9%)

8 (1.2%)

625
(96.2%)

2 (0.3%)

3 (0.5%)

2 (0.3%)

41 (6.3%)

597
(91.7%)

1 (0.2%)

117
(17.3%)

192
(28.2%)

34 (5.2%)

110
(16.9%)

349
(53.6%)

1 (0.2%)

10 (1.5%)

25 (3.8%)

130
(19.3%)
253
(37.2%)
174
(27.6%)

543
(80.9%)
118
(17.4%)
256
(40.6%)
100
(15.4%)

7 (1.1%)

54 (8.3%)
2 (0.3%)

33 (4.8%)

Table 2: Kappa Agreement Measures of Current Vaccine Status.
HPV (28.2%)1)
HepB (96.5%)
Dtap (44.1%)
IPV (91.9%)

HIB (54.2%)

619
(94.7%)

72 (11.4%)
3 (0.4%)

8 (1.2%)

Age
White
African American
Hispanic
Normal Weight
Overweight
Obese
HPV Current
Counseling about safe Sex
Offering Additional STI Testing
Medicaid
Commercial Insurance
*Mean ± standard deviation (std)

288
(42.3%)

3 (0.5%)
300
(44.0%)

7 Shots

1 (0.2%)

Dtap

IPV

HIB

Meningoccal

MMR

Varicella (31.9%)

0.02*

0.08*

0.02

-0.01

0.143**

0.01

0.13**

0.04**

0.29**

0.09**

0.04*
0.03

0.09**

0.08**
0.19**
0.05

-0.07

MMR (94.7%)
&
Kappa coefficient guide: <0 no agreement; 0-0.2 slight agreement; 0.21-0.4 fair agreement;
0.41-0.6 moderate agreement; 0.61-0.8 substantial agreement; 0.81-1.0 almost perfect agreement
*p-value < 0.05
**p-value < 0.01
Variable

47 (6.9%)

6 Shots

HepB

Meningoccal (80.9%)

Table 3: History of STI Data.

5 Shots

History of STI
No (n = 378)
Yes (n = 69)
15.2 ± 2.2*
17.4 ± 1.7
163 (43.5%)
10 (14.5%)
178 (47.5%)
57 (82.6%)
11 (2.9%)
1 (1.45%)
232 (62.5%)
32 (48.5%)
54 (14.6%)
32 (48.5%)
85 (22.9%)
21 (31.8%)
99 (26.1%)
30 (43.5%)
207 (54.9%)
67 (97.1%)
108/217 (49.8%)
66/68 (97.1%)
231 (64.9%)
47 (71.2%)
125 (35.1%)
19 (28.8%)

were associated with under immunization of young children [9].

Zimet et al [9] noted that sexually inexperienced individuals
were less likely to accept the HPV vaccine. Our findings were
similar as we did not demonstrate an increased risk of sexual
activity with HPV vaccination. We observed an increased risk

0.30**
0.06**

0.43**
0

0.10*

0.02*

0.08*
0

-0.12

0.06*
0.01

p-value
<0.0001

<0.0001

P=0.04 (overweight and obese vs. normal weight)
0.0052
<0.0001
<0.0001
Not Significant
Not Significant

of STI among subjects with current HPV vaccination status
compared to those who were not current; however, this finding
should be interpreted with caution since over a third of the charts
lacked STI information.

Our finding of a correlation between BMI and STI disagreed
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with Wee [10,11] who determined 1) that after adjustment for
age, race/ethnicity, and education, women with higher BMI were
less likely to report sexual behavioral risk factors than normalweight women; and 2) that HPV and sexual behavioral risk
factors for HPV and cervical cancer were not more prevalent in
obese than normal-weight women.

Our study demonstrated a trend of increased sexual activity
and increased STI as BMI increased. This finding differs slightly
from Kershaw [12] who concluded that overweight women were
more likely to have an STI than normal weight women; however,
obese women were less likely to have an STI compared to
normal weight women. This disagreement could reflect less welldeveloped decision making by our subjects as the average age of
our subjects was 14 years as well as the fact that sexual activity
among adolescents typically increases with age as does BMI.

There were two major limitations of the study. First, it was
a retrospective study and we had to rely on others for accurate
record-keeping. Secondly, it was a single center study of a practice
consisting of more than 70% Medicaid patients and our results
may not generalize to practices with a significantly different
payer mix. The strength of the study was the large sample size
and comprehensive look at adolescent immunizations in our
practice.
Our findings documented inadequate HPV vaccine status
among overweight/obese adolescents. Cervical cancer
incidence is higher in overweight/obese individuals. Hence
these individuals should be targeted more for HPV vaccination.
We recommend health care providers educate their adolescent
patients and parents on the increased risk of cervical cancer
especially among overweight/obese females as a means to
improve HPV vaccination compliance, and subsequently reduce
the incidence of cervical cancer in this at-risk population.

Acknowledgment

We thank the medical staff who helped retrieve the patients’
charts.

Copyright:
© 2014 Manickavasagam et al.

References
1. Ratcliff MB, Jenkins TM, Peiter-Purtill J, Noll JG, Zeller MH (2011) Risktaking behaviors of adolescents with extreme obesity: normative or
not? Pediatrics 127(5): 827-834.

2. Kimmel SR, Burns IT, Wolfe RM, Zimmerman RK (2007) Addressing
immunization barriers, benefits, and risks. J Fam Pract 56(2): S61-S69.
3. Bednarczyk RA, Davis R, Ault K, Orenstein W (2012) Sexual activityrelated outcomes after human papillomavirus vaccination of 11- to
12-year-olds. Pediatrics 30: 798-805.

4. Centers for Disease Control and Prevention (CDC) (2011) National
and state vaccination coverage among adolescents aged 13 through
17 years---United States, 2010. MMWR 60(33): 1117-1123.

5. Ghazal-Aswad, S. (2008) Cervical cancer prevention in the human
papilloma virus vaccine era. Ann N Y Acad Sci 1138: 253-256.

6. Maruthur NM, Bolen S, Brancati FL, Clark JM (2009) The association of
obesity and cervical cancer screening: a systematic review and metaanalysis. Obesity (Silver Spring) 17(2): 375-381.

7. Deshmukh-Taskar P, Nicklas TA, Yang S-J, Zakeri I, et al. (2006)
Tracking of overweight status from childhood to young adulthood: the
Bogalusa Heart Study. Eur J Clin Nutr 60(1): 48-57.
8. Aldrich T, Hackley B (2010) The impact of obesity on gynecologic
cancer screening: an integrative literature review. J Midwifery
Womens Health 55(4): 344-356.
9. Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, et al. (2005)
Parental attitudes about sexually transmitted infection vaccination for
their adolescent children. Arch Pediatr Adolesc Med 159(2): 132-137.
10. Wee CC, Huang A, Juskey KW, McCarthy EP. (2008) Obesity and the
likelihood of sexual behavioral risk factors for HPV and cervical
cancer. Obesity 16(11): 2552-2555.
11. Wee CC, Phillips RS & McCarthy EP (2005) BMI and cervical screening
among white, African-American, and Hispanic women in the United
States. Obes Res 13(7): 1275-1280.
12. Kershaw TS, Arnold A, Lewis JB, Magriples U (2010) The skinny on
sexual risk: the effect of BMI on STI incidence and risk. AIDS Behav
15(7): 1527-1538.

Citation: Manickavasagam E, Dai H, Griffith JR (2014) HPV Vaccine Status and BMI Correlation. Obes Control Ther 1(1): 1-4. http://
dx.doi.org/10.15226/2374-8354/1/1/00104

Page 4 of 4

